Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing.
about
Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK.Safety and efficacy of a novel iopromide-based paclitaxel-eluting balloon following bare metal stent implantation in rabbit aorta abdominalis.Techniques in Vascular and Interventional Radiology Drug Delivery Technologies in the Superficial Femoral ArteryBiological effect on drug distribution and vascular healing via paclitaxel-coated balloon technology in drug eluting stent restenosis swine model.Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: 12-Month Outcomes from the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies.Six-Month Results From the Initial Randomized Study of the Ranger Paclitaxel-Coated Balloon in the Femoropopliteal Segment.Controlling drug delivery from coronary stents: are we aiming for the right targets?Systematic Review and Meta-analysis of Randomized Controlled Trials of Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Arteries: Role of Paclitaxel Dose and Bioavailability.An update on the clinical use of drug-coated balloons in percutaneous coronary interventions.Dextran sulfate as a drug delivery platform for drug-coated balloons: Preparation, characterization, in vitro drug elution, and smooth muscle cell response.Angiographic classification of patterns of restenosis following femoropopliteal artery intervention: A proposed scoring system.Stellarex drug-coated balloon for treatment of femoropopliteal arterial disease-The ILLUMENATE Global Study: 12-Month results from a prospective, multicenter, single-arm study.Computational Model of Drug-Coated Balloon Delivery in a Patient-Specific Arterial Vessel with Heterogeneous Tissue Composition.Commentary: Next-Generation Drug-Coated Balloons: A New Era for Endovascular Therapy of the Femoropopliteal Arteries?
P2860
Q36920052-68F42929-A60A-42C7-850D-DF791FAD9475Q37044202-9CB37803-F2C5-474C-9C01-3266823587FBQ37102287-624E6DC9-8E5D-45B0-A3BD-2EBDF8F34A8BQ37337286-574F8BB7-9397-4A6F-81C1-B022EEC5B146Q38373588-CED4EB81-4195-41DB-9726-3591F15EE221Q38376199-F9ABC0FB-E8C4-4AF7-8E8B-233CF15BB968Q38543392-856F2F8A-5427-442C-AA0F-6C930D17A66FQ38715649-94977971-7421-4F67-9A2F-AD15FF0FB16BQ38754274-2E5DEA0D-E57A-4581-882A-11C12E7BACEFQ41364881-1F5D47D2-9DD3-4242-8292-195687E62754Q46611491-B36E9133-1636-44DC-BED6-37F0A803C823Q47396762-100FB6D0-291A-4E94-BFA5-78154ED483F4Q50496849-B593FA71-477E-4F84-B09D-C097C22F86B3Q53261233-9E01BE1E-D073-45CA-851F-F3E671F47242
P2860
Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Mechanisms of tissue uptake an ...... mal proliferation and healing.
@en
Mechanisms of tissue uptake an ...... mal proliferation and healing.
@nl
type
label
Mechanisms of tissue uptake an ...... mal proliferation and healing.
@en
Mechanisms of tissue uptake an ...... mal proliferation and healing.
@nl
prefLabel
Mechanisms of tissue uptake an ...... mal proliferation and healing.
@en
Mechanisms of tissue uptake an ...... mal proliferation and healing.
@nl
P2093
P2860
P1433
P1476
Mechanisms of tissue uptake an ...... mal proliferation and healing.
@en
P2093
Armando Tellez
Dan Langanki
Greg L Kaluza
Juan F Granada
Mark Stenoien
Martin B Leon
Michael R Jaff
Piotr P Buszman
Robert S Schwartz
William Gray
P2860
P304
P356
10.1136/OPENHRT-2014-000117
P577
2014-08-06T00:00:00Z